Has Peck Ong received payments from drug or device companies?

Yes. Drug and device makers reported $83,123 in general payments to Peck Ong across 77 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Peck Ong did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Peck Ong come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Peck Ong

Pediatric Allergy/Immunology · Los Angeles, CANPI 1659478865

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $63,335 of the $83,123 with a category attached, or 76.2%. 8 manufacturers reported payments, led by Pfizer at 27.9% of the total. Among pediatric allergy/immunology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$83,123in general payments, 2019–2025

Across 77 payments — averaging $1079.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Pfizer$23K
Dermavant Sciences, Inc.$19K
AbbVie$13K
Regeneron$10K
Amgen$10K
Incyte Corporation$3K
plus $4K from 2 others

$493,630in research payments, 2019–2025

Across 280 payments — averaging $1762.96 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Regeneron$197K
Sanofi$180K
Pfizer$49K
LEO Pharma AS$44K
Incyte Corporation$22K

What the payments were for

Consulting fees$63,33576%
Speaking & faculty fees$10,73013%
Travel & lodging$6,8788%
Food & beverage$2,1803%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Pfizer	8	$23,213
Dermavant Sciences, Inc.	23	$18,992
AbbVie	16	$13,413
Regeneron	12	$10,336
Amgen	15	$9,680
Incyte Corporation	1	$3,229
Sanofi	1	$2,499
Janssen Global Services, LLC	1	$1,760

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

EUCRISA$20,515
TAPINAROF$18,396
DUPIXENT$12,490
Rinvoq$4,888
Skyrizi$1,034

How this compares

$83,123 in reported general payments places this provider in the 95th percentile of 48 pediatric allergy/immunology providers in California.

See all pediatric allergy/immunology providers in California →

Other pediatric allergy/immunology in Los Angeles

Manish ButteLos Angeles$357K
Maria Garcia-LloretLos Angeles$39K
Talal ChatilaLos Angeles$30K
Ewald StiehmLos Angeles$24K
Neema IzadiLos Angeles$6K
Elizabeth FeuilleLos Angeles$6K
Marilyn LiLos Angeles$5K
Caroline KuoLos Angeles$418
Joseph ChurchLos Angeles$222
Stephanie RodriguezLos Angeles$157

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →